Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.

Bibliographic Details
Main Authors:	Brennan, F, Cope, A, Katsikis, P, Gibbons, D, Maini, R, Feldmann, M
Format:	Journal article
Language:	English
Published:	1995

Similar Items

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
by: Maini, R, et al.
Published: (1995)

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1992)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
by: Elliott, M, et al.
Published: (1993)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
by: Feldmann, M, et al.
Published: (1997)

INCREASED EXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTORS ON CELLS ISOLATED FROM RHEUMATOID-ARTHRITIS SYNOVIAL JOINTS
by: Gibbons, D, et al.
Published: (1992)

TNF alpha as a therapeutic target in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1994)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
by: Davis, D, et al.
Published: (1997)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
by: Feldmann, M
Published: (1996)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1997)

Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.
by: Brennan, F, et al.
Published: (1992)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
by: Williams, R, et al.
Published: (2000)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
by: Maini, R, et al.
Published: (1999)

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
by: Haworth, C, et al.
Published: (1991)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
by: Elliott, M, et al.
Published: (1994)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1994)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
by: Elliot, M, et al.
Published: (2008)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
by: Maini, R, et al.
Published: (1993)

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
by: Brennan, F, et al.
Published: (1997)

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
by: Buchan, G, et al.
Published: (1988)

TNF alpha--a pivotal role in rheumatoid arthritis?
by: Brennan, F, et al.
Published: (1992)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
by: Maini, R, et al.
Published: (1998)

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
by: Deleuran, B, et al.
Published: (1992)

Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
by: Katsikis, P, et al.
Published: (1994)

Effects of treatment of rheumatoid arthritis patients with an antibody against tumour necrosis factor alpha on reticuloendothelial and intrapulmonary granulocyte traffic.
by: Taylor, P, et al.
Published: (1999)

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
by: Chu, C, et al.
Published: (1991)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (2001)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
by: Maini, R, et al.
Published: (1994)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
by: Paleolog, E, et al.
Published: (1996)

TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action.
by: Brennan, F, et al.
Published: (1995)

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
by: Elliott, M, et al.
Published: (1994)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1995)

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
by: Paleolog, E, et al.
Published: (1998)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
by: Maini, R, et al.
Published: (1994)

Rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1996)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
by: Ulfgren, A, et al.
Published: (2000)

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2000)

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.
by: McCann, F, et al.
Published: (2010)

Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (2002)

Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis.
by: Deleuran, B, et al.
Published: (1992)

From the laboratory to the clinic: Evaluation of cytokines in rheumatoid arthritis highlights TNF-alpha as a new therapeutic target
by: Feldmann, M, et al.
Published: (1994)